Indoco Remedies has informed that it enclosed a Press release regarding receipt of final approval from USFDA, for the Company’s Abbreviated New Drug Application for Cetirizine Hydrochloride Tablets USP, 10 mg (OTC), to market a generic equivalent of Zyrtec Allergy Tablets, 10 mg of Johnson & Johnson Consumer Inc.
The above information is a part of company’s filings submitted to BSE.